Atlas Trials

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

Clinical trial NCT07440212 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07440212
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Esophagus Cancer
Start date
2026-02-01
Primary completion
2027-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.